Back to Journals » Patient Preference and Adherence » Volume 3

Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy

Authors Barton J

Published 17 November 2009 Volume 2009:3 Pages 335—344

DOI https://doi.org/10.2147/PPA.S5835

Review by Single-blind

Peer reviewer comments 2

Jennifer L Barton

Division of Rheumatology, University of California San Francisco, San Francisco, California, USA

Abstract: Significant advances in the treatment of rheumatoid arthritis (RA) have been made over the past 10 years with the introduction of biologic therapies, such as the TNF inhibitors. With these medications, many patients with RA have seen significant improvement in symptoms, function, and quality of life. However, with the introduction of the biologics, decision-making for this chronic disease that affects up to 1% of the population has become even more complex. Patient preferences for mode and frequency of administration, and for certain risks vs benefits as well as medication beliefs are central to uptake and adherence to these medications. This review examines the current literature on patient satisfaction, adherence, and preference for biologic therapy in RA.

Keywords: rheumatoid arthritis, patient preference, adherence, biologics

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]